Immix Biopharma, Inc.

/Immix Biopharma, Inc.

IPO

Immix Biopharma, Inc.

Biopharmaceutical

We are a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics (“TSTx”)TM in oncology and inflammation.

Symbol

IMMX

Price Range
$5.00 - $6.00

Final Shares
3,825,000

Anticipated Date
December 16, 2021

Underwriters
FORDHAM FINANCIAL MANAGEMENT, INC.

This offering is no longer available

To view the prospectus for Immix Biopharma, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange